O
13.34
-0.54 (-3.89%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Oric Pharmaceuticals, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
0.0
| 分析师共识 | 3.0 |
| 内部交易活动 | -1.5 |
| 价格波动 | -4.5 |
| 技术平均移动指标 | -1.0 |
| 技术振荡指标 | 4.0 |
| 平均 | 0.00 |
|
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 7.93% |
| 机构持股比例 | 102.70% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Column Group Llc | 31 Dec 2025 | 3,540,777 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 25.00 (HC Wainwright & Co., 87.41%) | 购买 |
| 25.00 (Wells Fargo, 87.41%) | 购买 | |
| 中 | 22.00 (64.92%) | |
| 低 | 17.00 (Citigroup, 27.44%) | 购买 |
| 平均值 | 21.80 (63.42%) | |
| 总计 | 5 购买 | |
| 平均价格@调整类型 | 11.89 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Citigroup | 24 Feb 2026 | 17.00 (27.44%) | 购买 | 13.42 |
| HC Wainwright & Co. | 24 Feb 2026 | 25.00 (87.41%) | 购买 | 13.42 |
| Wedbush | 24 Feb 2026 | 20.00 (49.93%) | 购买 | 13.42 |
| 13 Jan 2026 | 20.00 (49.93%) | 购买 | 10.14 | |
| Piper Sandler | 07 Jan 2026 | 22.00 (64.92%) | 购买 | 8.68 |
| Wells Fargo | 08 Dec 2025 | 25.00 (87.41%) | 购买 | 10.52 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| PISCITELLI DOMINIC | - | 13.42 | -52,000 | -697,840 |
| 累积净数量 | -52,000 | |||
| 累积净值 ($) | -697,840 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 13.42 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| PISCITELLI DOMINIC | 职员 | 24 Feb 2026 | 自动卖出 (-) | 52,000 | 13.42 | 697,840 |
| PISCITELLI DOMINIC | 职员 | 24 Feb 2026 | 执行期权 | 52,000 | - | - |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合